Dysregulation of RA lipid metabolism is characterized by elevated LDL-C levels, impaired HDL-C function, and abnormal PCSK9 accumulation, which directly drive inflammation and immune dysregulation. The gene discussed is PCSK9; the disease is rheumatoid arthritis.